Patent details
EP2324853 Title: Lixisenatide as add-on to metformin in the treatment of diabetes type 2
Basic Information
- Publication number:
- EP2324853
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP091758763
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Lixisenatide as add-on to metformin in the treatment of diabetes type 2
- French Title of Invention:
- Lixisenatide en tant que traitement d'appoint à la metformine dans le diabète de type 2
- German Title of Invention:
- Lixisenatid zusätzlich zu Metformin bei der Behandlung von Diabetes Typ 2
- SPC Number:
Dates
- Filing date:
- 13/11/2009
- Grant date:
- 26/08/2015
- EP Publication Date:
- 26/08/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/05/2011
- EP B1 Publication Date:
- 26/08/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/11/2015
- Expiration date:
- 13/11/2029
- Renunciation date:
- Revocation date:
- 10/12/2020
- Annulment date:
Owner
- From:
- 13/11/2009
- Name:
- Sanofi-Aventis Deutschland GmbH
- Address:
- Brüningstraße 50, 65929 Frankfurt am Main, Germany (DE)
Inventor
1
- Name:
- Zhou Tianyue
- Address:
- United States (US)
2
- Name:
- Sert-Langeron Caroline
- Address:
- France (FR)
3
- Name:
- Silvestre Louise
- Address:
- France (FR)
Classification
- Main IPC Class:
- A61K 31/155;
Publication
European Patent Bulletin
- Issue number:
- 202109
- Publication date:
- 03/03/2021
- Description:
- Revocation of the European patent
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|